CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing proprietary targeted medicines primarily for cancer treatment, today announced that it will be presenting data from its pipeline of oncology programs at the upcoming American Association for Cancer Research (AACR) Annual Meeting being held in San Diego, CA, April 12-16.
